# Neoadjuvant Toripalimab or Toripalimab in Combination With Carboplatin and Nab-paclitaxel in Untreated HNSCC (HNSCC-002)

> **NCT04807140** · PHASE2 · RECRUITING · sponsor: **Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University** · enrollment: 57 (estimated)

## Conditions studied

- Head and Neck Squamous Cell Carcinoma

## Interventions

- **DRUG:** Toripalimab, nab-paclitaxel, carboplatin
- **DRUG:** Toripalimab
- **PROCEDURE:** Surgical resection

## Key facts

- **NCT ID:** NCT04807140
- **Lead sponsor:** Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-07-08
- **Primary completion:** 2023-12-01
- **Final completion:** 2027-01-01
- **Target enrollment:** 57 (ESTIMATED)
- **Last updated:** 2023-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04807140

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04807140, "Neoadjuvant Toripalimab or Toripalimab in Combination With Carboplatin and Nab-paclitaxel in Untreated HNSCC (HNSCC-002)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04807140. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*